Tango Therapeutics, Inc.
TNGXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Tango Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Source: Tango Therapeutics, Inc. — 10-K filed Mar 5, 2026
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 23, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Bank of New York Mellon Corp | 2026-03-31 | 318,458 | $6.66M | SEC filing |
| RHUMBLINE ADVISERS | 2026-03-31 | 126,603 | $2.65M | SEC filing |
| MANGROVE PARTNERS IM, LLC | 2026-03-31 | 12,557 | $263K | SEC filing |
| GOLDMAN SACHS GROUP INC | 2026-03-31 | 5,076,392 | $106M | SEC filing |
| BESSEMER GROUP INC | 2026-03-31 | 708,398 | Not shown | SEC filing |
| Allworth Financial LP | 2026-03-31 | 563 | $11.8K | SEC filing |
| ALLSTATE CORP | 2026-03-31 | 32,047 | $670K | SEC filing |
| MAI Capital Management | 2026-03-31 | 18 | $377 | SEC filing |
| Integral Health Asset Management, LLC | 2026-03-31 | 450,000 | $9.41M | SEC filing |
| NEW YORK STATE COMMON RETIREMENT FUND | 2026-03-31 | 33,476 | $700K | SEC filing |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2026-03-31 | 10,647 | $223K | SEC filing |
| IFP Advisors, Inc | 2026-03-31 | 233 | $4.87K | SEC filing |
| Mirae Asset Global Investments Co., Ltd. | 2026-03-31 | 7,025 | $147K | SEC filing |
| MassMutual Private Wealth & Trust, FSB | 2026-03-31 | 19 | $397 | SEC filing |
| GF FUND MANAGEMENT CO. LTD. | 2026-03-31 | 3,011 | $63K | SEC filing |
| Creative Planning | 2026-03-31 | 52,907 | $1.11M | SEC filing |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 2026-03-31 | 108,218 | $2.26M | SEC filing |
| Nantahala Capital Management, LLC | 2026-03-31 | 1,250,452 | $26.2M | SEC filing |
| VICTORY CAPITAL MANAGEMENT INC | 2026-03-31 | 52,801 | $1.1M | SEC filing |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. | 2026-03-31 | 20,463 | $428K | SEC filing |
- Each value is checked against Tango Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Tango Therapeutics, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Tango Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-09-05 · TRV GP IV, LLC: Larger than 69 of the 73 other insider sales of Common Stock on file. SEC filing
- 2025-08-19 · TRV GP IV, LLC: Larger than 70 of the 73 other insider sales of Common Stock on file. SEC filing
- 2024-11-07 · EcoR1 Capital, LLC: Larger than 71 of the 73 other insider sales of Common Stock on file. SEC filing
- 2024-11-06 · Davis Aaron I.: Larger than all 73 other insider sales of Common Stock on file. SEC filing
- 2024-11-06 · EcoR1 Capital, LLC: Larger than 72 of the 73 other insider sales of Common Stock on file. SEC filing
- 2024-10-25 · Davis Aaron I.: Larger than 68 of the 73 other insider sales of Common Stock on file. SEC filing
- 2024-10-21 · Davis Aaron I.: Larger than 67 of the 73 other insider sales of Common Stock on file. SEC filing
- 2024-07-17 · TRV GP IV, LLC: Larger than 66 of the 73 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-01 | Crystal Adam · President, R&D | Common Stock | S — Open market or private sale | −6,140 | 22.25 | SEC filing |
| 2026-06-01 | Crystal Adam · President, R&D | Common Stock | S — Open market or private sale | −20,860 | 23.06 | SEC filing |
| 2026-05-01 | Crystal Adam · President, R&D | Common Stock | S — Open market or private sale | −25,900 | 21.19 | SEC filing |
| 2026-05-01 | Crystal Adam · President, R&D | Common Stock | S — Open market or private sale | −1,100 | 22.00 | SEC filing |
| 2026-04-15 | Crystal Adam · President, R&D | Common Stock | S — Open market or private sale | −38,460 | 25.00 | SEC filing |
| 2026-04-01 | Crystal Adam · President, R&D | Common Stock | S — Open market or private sale | −27,000 | 21.20 | SEC filing |
| 2026-03-25 | Crystal Adam · President, R&D | Common Stock | S — Open market or private sale | −12,000 | 20.11 | SEC filing |
| 2026-03-05 | Crystal Adam · President, R&D | Common Stock | S — Open market or private sale | −20,251 | 15.00 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-19 | Azelby Robert · Director | Common Stock | A — Grant, award, or other acquisition | +5,740 | SEC filing |
| 2026-06-19 | Azelby Robert · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +35,910 | SEC filing |
| 2026-06-05 | Calhoun Lesley Ann · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +25,000 | SEC filing |
| 2026-06-05 | Ketchum John B · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +25,000 | SEC filing |
| 2026-06-05 | Rothenberg Mace · Director | Common Stock | A — Grant, award, or other acquisition | +4,000 | SEC filing |
| 2026-06-05 | Ketchum John B · Director | Common Stock | A — Grant, award, or other acquisition | +4,000 | SEC filing |
| 2026-06-05 | Rothenberg Mace · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +25,000 | SEC filing |
| 2026-06-05 | Lee Sung · Director | Common Stock | A — Grant, award, or other acquisition | +570 | SEC filing |
Showing 8 of 20 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2024-09-03 | Davis Aaron I. · Other | Stock Option (Right to Buy) | J — Other acquisition or disposition | +65,000 | SEC filing |
Showing 1 of 1 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.